Orbimed Advisors - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$32,226,000
-5.3%
3,322,300
+4.9%
0.33%
+2.5%
Q1 2021$34,012,000
-21.9%
3,166,900
+7.0%
0.32%
-16.5%
Q4 2020$43,545,000
+144.6%
2,960,200
+136.3%
0.38%
+70.1%
Q3 2020$17,799,000
+81.7%
1,252,600
+3.4%
0.22%
+62.3%
Q2 2020$9,797,000
+202.8%
1,211,000
+51.2%
0.14%
+155.6%
Q1 2020$3,236,000801,0000.05%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders